Long Term Safety of Immediate-release Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease
Public ClinicalTrials.gov record NCT02251275. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3b, Multi-center, Open-label Trial to Evaluate the Long Term Safety of Immediate-release Tolvaptan (OPC-41061, 30 mg to 120 mg/Day, Split Dose) in Subjects With Autosomal Dominant Polycystic Kidney Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the trial was to evaluate and describe the long term safety of tolvaptan in participants with autosomal dominant polycystic kidney disease (ADPKD).
Study identification
- NCT ID
- NCT02251275
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,803 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 17, 2014 (Actual)
- Primary completion
- Nov 9, 2018 (Actual)
- Completion
- Nov 9, 2018 (Actual)
- Last update posted
- Nov 27, 2019
2014 – 2018
United States locations
- U.S. sites
- 81
- U.S. states
- 31
- U.S. cities
- 73
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Birmingham | Alabama | 35233 | — |
| Not listed | Huntsville | Alabama | 35805 | — |
| Not listed | Mobile | Alabama | 36617 | — |
| Not listed | Phoenix | Arizona | 85381 | — |
| Not listed | Tempe | Arizona | 85284 | — |
| Not listed | Tucson | Arizona | 85745 | — |
| Not listed | La Jolla | California | 92037 | — |
| Not listed | Los Angeles | California | 90022 | — |
| Not listed | Los Angeles | California | 90095 | — |
| Not listed | San Francisco | California | 94143 | — |
| Not listed | Stanford | California | 94305 | — |
| Not listed | Aurora | Colorado | 80045 | — |
| Not listed | Denver | Colorado | 80204 | — |
| Not listed | Denver | Colorado | 80210 | — |
| Not listed | New Haven | Connecticut | 06520 | — |
| Not listed | Hudson | Florida | 34667 | — |
| Not listed | Jacksonville | Florida | 32216 | — |
| Not listed | Miami | Florida | 33150 | — |
| Not listed | Ocala | Florida | 34471 | — |
| Not listed | Port Charlotte | Florida | 33952 | — |
| Not listed | Tampa | Florida | 33614 | — |
| Not listed | Atlanta | Georgia | 30322 | — |
| Not listed | Augusta | Georgia | 30909 | — |
| Not listed | Meridian | Idaho | 83642 | — |
| Not listed | Chicago | Illinois | 60611 | — |
| Not listed | Chicago | Illinois | 60637 | — |
| Not listed | Kansas City | Kansas | 66160 | — |
| Not listed | Wichita | Kansas | 67214 | — |
| Not listed | Baton Rouge | Louisiana | 70808 | — |
| Not listed | Baltimore | Maryland | 21201 | — |
| Not listed | Baltimore | Maryland | 21224 | — |
| Not listed | Greenbelt | Maryland | 20770 | — |
| Not listed | Rockville | Maryland | 20850 | — |
| Not listed | Boston | Massachusetts | 02111 | — |
| Not listed | Springfield | Massachusetts | 01107 | — |
| Not listed | Detroit | Michigan | 48202 | — |
| Not listed | Grand Rapids | Michigan | 49506 | — |
| Not listed | Kalamazoo | Michigan | 49007 | — |
| Not listed | Pontiac | Michigan | 48341 | — |
| Not listed | Roseville | Michigan | 48066 | — |
| Not listed | Rochester | Minnesota | 55905 | — |
| Not listed | St Louis | Missouri | 63110 | — |
| Not listed | Las Vegas | Nevada | 89106 | — |
| Not listed | Reno | Nevada | 89511 | — |
| Not listed | Eatontown | New Jersey | 07724 | — |
| Not listed | Voorhees Township | New Jersey | 08043 | — |
| Not listed | Buffalo | New York | 14219 | — |
| Not listed | Laurelton | New York | 11413 | — |
| Not listed | Mineola | New York | 11501 | — |
| Not listed | New York | New York | 10021 | — |
| Not listed | New York | New York | 10032 | — |
| Not listed | Asheville | North Carolina | 28801 | — |
| Not listed | Chapel Hill | North Carolina | 27599 | — |
| Not listed | Charlotte | North Carolina | 28207 | — |
| Not listed | Winston-Salem | North Carolina | 27103 | — |
| Not listed | Fargo | North Dakota | 58102 | — |
| Not listed | Akron | Ohio | 44302 | — |
| Not listed | Cincinnati | Ohio | 45206 | — |
| Not listed | Cincinnati | Ohio | 45229 | — |
| Not listed | Cleveland | Ohio | 44106 | — |
| Not listed | Columbus | Ohio | 43210 | — |
| Not listed | Portland | Oregon | 97210 | — |
| Not listed | Bethlehem | Pennsylvania | 18017 | — |
| Not listed | Doylestown | Pennsylvania | 18901 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Charleston | South Carolina | 29425 | — |
| Not listed | Columbia | South Carolina | 29203 | — |
| Not listed | Orangeburg | South Carolina | 29118 | — |
| Not listed | Knoxville | Tennessee | 37923 | — |
| Not listed | Nashville | Tennessee | 37205 | — |
| Not listed | Nashville | Tennessee | 37232 | — |
| Not listed | Arlington | Texas | 76015 | — |
| Not listed | Houston | Texas | 77004 | — |
| Not listed | Houston | Texas | 77030 | — |
| Not listed | McAllen | Texas | 78503 | — |
| Not listed | Burlington | Vermont | 05401 | — |
| Not listed | Arlington | Virginia | 22207 | — |
| Not listed | Charlottesville | Virginia | 22908 | — |
| Not listed | Norfolk | Virginia | 23507 | — |
| Not listed | Wenatchee | Washington | 98801 | — |
| Not listed | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 129 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02251275, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 27, 2019 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02251275 live on ClinicalTrials.gov.